EARLY DETECTION OF HEART FAILURE RISK IN PATIENTS WITH DIABETES

Barakayeva Nigina O’tkir qizi

Tashkent State Medical University

Keywords: Diabetes, heart failure, early detection, biomarkers, echocardiography, natriuretic peptides, cardiovascular risk, subclinical dysfunction, risk stratification.

---

Abstract

This article explores strategies for the early detection of heart failure (HF) risk in patients with diabetes. Diabetes significantly increases the incidence of HF due to metabolic, vascular, and structural cardiac changes. Early identification of atrisk individuals allows timely intervention and prevents progression to symptomatic heart failure. The study reviews the use of biomarkers, imaging techniques, and functional assessments, highlighting their diagnostic value and clinical relevance in diabetic patients.

---

References

1. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the

diagnosis and treatment of acute and chronic heart failure. Eur Heart J.

2021;42:3599–3726.

2. Seferović PM, Petrie MC, Filippatos G, et al. Type 2 diabetes mellitus and heart

failure: a position statement from the Heart Failure Association of the ESC. Eur

J Heart Fail. 2018;20:853–872.

3. Zile MR, Baicu CF, Gaasch WH. Diastolic heart failure—abnormalities in active

relaxation and passive stiffness of the left ventricle. N Engl J Med.

2004;350:1953–1959.

4. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol. 2007;50:2357–

2368.

5. Paulus WJ, Tschöpe C. A novel paradigm for heart failure with preserved

ejection fraction. J Am Coll Cardiol. 2013;62:263–271.

6. Packer M, Anker SD, Butler J, et al. Cardiovascular and renal outcomes with

empagliflozin in heart failure. N Engl J Med. 2020;383:1413–1424.

7. Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham

study. JAMA. 1979;241:2035–2038.

8. From AM, Scott CG, Chen HH. The development of heart failure in patients with

diabetes mellitus and preclinical diastolic dysfunction: a population-based study.

J Am Coll Cardiol. 2009;54:789–796.

9. Haufe S, Scherhag A, Engelhardt S, et al. Myocardial fibrosis and tissue

characterization in diabetic cardiomyopathy: cardiac MRI studies. Diabetes

Care. 2010;33:1429–1435.